Detalhe da pesquisa
1.
Different prognostic effects of core-binding factor positive AML with Korean AML registry data.
Ann Hematol
; 98(5): 1135-1147, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30758645
2.
Enhanced Anti-Leukemic Effects through Induction of Immunomodulating Microenvironment by Blocking CXCR4 and PD-L1 in an AML Mouse Model.
Immunol Invest
; 48(1): 96-105, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30204524
3.
Matrix Metalloproteinase-9 in Monocytic Myeloid-Derived Suppressor Cells Correlate with Early Infections and Clinical Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(1): 32-42, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28844945
4.
Impact of an Additional Chromosome on the Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome-Positive Acute Myeloid Leukemia in Adults.
Biol Blood Marrow Transplant
; 24(8): 1621-1628, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29698793
5.
Comparison of transplant-specific prognostic scoring systems in haploidentical transplantation for myelodysplastic syndrome.
Eur J Haematol
; 2018 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29758108
6.
Role of CXCR4 Antagonist in Megakaryocyte Reinstatement with Increased Sinusoidal Vessel Density.
Adv Exp Med Biol
; 1072: 419-422, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30178381
7.
Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
Biol Blood Marrow Transplant
; 23(9): 1498-1508, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28554856
8.
Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
Biol Blood Marrow Transplant
; 23(4): 588-597, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28089879
9.
Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
Hematol Oncol
; 35(1): 17-24, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25782369
10.
Outcomes of allogeneic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria with or without aplastic anemia.
Eur J Haematol
; 99(4): 336-343, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675769
11.
Clinical significance of pre-transplant circulating CD3+ CD4+ CD161+ cell frequency on the occurrence of neutropenic infections after allogeneic stem cell transplantation.
Transpl Infect Dis
; 19(1)2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27910184
12.
Negative Impact of Unidirectional Host-versus-Graft Killer Cell Immunoglobulin-like Receptor Ligand Mismatch on Transplantation Outcomes after Unmanipulated Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 22(2): 316-323, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26415557
13.
Circulating immune cell phenotype can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.
Cancer Immunol Immunother
; 65(8): 983-94, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27342591
14.
Cytogenetic profiles of 2806 patients with acute myeloid leukemia-a retrospective multicenter nationwide study.
Ann Hematol
; 95(8): 1223-32, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27230620
15.
Outcome of allogeneic hematopoietic stem cell transplantation for cytogenetically normal AML and identification of high-risk subgroup using WT1 expression in association with NPM1 and FLT3-ITD mutations.
Genes Chromosomes Cancer
; 54(8): 489-499, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26054017
16.
CD161(+) T cells as predictive markers for acute graft-versus-host disease.
Biol Blood Marrow Transplant
; 21(3): 421-8, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25543092
17.
Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome.
Biol Blood Marrow Transplant
; 21(2): 342-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25459640
18.
A well-tolerated regimen of 800 cGy TBI-fludarabine-busulfan-ATG for reliable engraftment after unmanipulated haploidentical peripheral blood stem cell transplantation in adult patients with acute myeloid leukemia.
Biol Blood Marrow Transplant
; 21(1): 119-29, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25300871
19.
Wilms tumor gene 1 expression as a predictive marker for relapse and survival after hematopoietic stem cell transplantation for myelodysplastic syndromes.
Biol Blood Marrow Transplant
; 21(3): 460-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25460359
20.
Impact of extramedullary plasmacytomas on outcomes according to treatment approach in newly diagnosed symptomatic multiple myeloma.
Ann Hematol
; 94(3): 445-52, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25257340